This paper is only available as a PDF. To read, Please Download here.
Abstract
Preimplantation HLA typing has been introduced for the treatment of affected siblings, requiring HLA-identical stem cell transplantation. This was applied either in combination with preimplantation genetic diagnosis (PGD) to ensure that the preselected HLA-matched embryos were also free of the genetic disorder, or without PGD, with the only purpose of selecting and transferring the HLA-matched embryos. Because patients requesting preimplantation HLA typing are usually of advanced reproductive age, aneuploidy testing allows not only the avoidance of the birth of children with chromosomal disorders, but also improvement of the reproductive outcome, which is still not sufficiently high in preimplantation HLA typing at the present time. This study presents the results of the first experience of preimplantation HLA typing combined with aneuploidy testing, demonstrating feasibility and impact of aneuploidy testing on the accuracy and outcome of preimplantation HLA typing. Of a total of 138 cycles performed, 87 were combined with PGD and 52 without testing for the causative gene, of which aneuploidy testing was performed in 27 cycles, allowing the preselection and transfer of only those HLA-matched embryos that were also euploid. Although the euploid HLA-identical embryos were available for transfer in only half of these cycles, pregnancy and birth of unaffected HLA-identical children were observed in approximately half of these cycles, suggesting the potential usefulness of incorporating aneuploidy testing into preimplantation HLA typing.
Keywords
References
- Ethics of PGD: thoughts on the consequences of typing HLA in embryos.Reproductive BioMedicine Online. 2004; 9: 222-224
- Conception for donation.Journal of the American Medical Association. 2004; 291: 2125-2126
- The beneficial effects of PGD for aneuploidy support extensive clinical application.Reproductive BioMedicine Online. 2004; 10: 633-640
- Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with poor prognosis: identification of the categories for which it should be proposed.Fertility and Sterility. 1999; 72: 837-844
- Clinical aspects of preimplantation genetic diagnosis of single gene disorders combined with HLA typing.Reproductive BioMedicine Online. 2004; 9: 529-532
- Preimplantation HLA typing and stem cell transplantation.Reproductive BioMedicine Online. 2004; 9: 205-209
- Preimplantation diagnosis and HLA typing for haemoglobin disorders.Reproductive BioMedicine Online. 2005; 11: 362-370
- Chromosomal abnormalities in a series of 6733 human oocytes in preimplantation diagnosis of age-related aneuploidies.Reproductive BioMedicine Online. 2003; 6: 54-59
- Preimplantation genetic diagnosis of numerical and structural chromosome abnormalities.Reproductive BioMedicine Online. 2002; 4: 183-196
- Improved implantation after preimplantation genetic diagnosis of aneuploidy.Reproductive BioMedicine Online. 2003; 7: 91-97
- Positive outcome after preimplantation diagnosis of aneuploidy in human embryos.Human Reproduction. 1999; 14: 2191-2199
- Preimplantation genetic diagnosis with HLA matching.Reproductive BioMedicine Online. 2004; 9: 210-221
- Extending preimplantation genetic diagnosis: the ethical debate. Ethical issues in new uses of preimplantation genetic diagnosis.Human Reproduction. 2003; 18: 465-471
- Novel universal approach for preimplantation genetic diagnosis of β-thalassemia in combination with HLA matching of embryos.Human Reproduction. 2004; 19: 700-708
- Atlas of Preimplantation Genetic Diagnosis. 2nd edn. Taylor and Francis, London and New York2005: 288
- Preimplantation HLA typing.Journal of the American Medical Association. 2004; 291: 2079-2085
- Preimplantation diagnosis for Fanconi anemia combined with HLA matching.Journal of the American Medical Association. 2001; 285: 3130-3133
- Designer babies-are they reality yet? Case report: simultaneous preimplantation genetic diagnosis for Fanconi anemia and HLA typing for cord blood transplantation.Reproductive BioMedicine Online. 2000; 1: 31
Biography
Dr Svetlana Rechitsky is a graduate of Kharkov University's Genetics Faculty, and received her PhD in Experimental Molecular Embryology from the Second Moscow Medical Institute in 1986. She moved to the Reproductive Genetics Institute in 1989 to head the DNA laboratory, which has performed the largest preimplantation genetic diagnosis (PGD) series for single gene disorders, with PGD design for the majority of these disorders developed for the first time. She has published more than 30 papers in the field of PGD, including a key contribution to the recently published Atlas of Preimplantation Genetic Diagnosis.
Article info
Publication history
Accepted:
September 30,
2005
Received:
August 3,
2005
Identification
Copyright
© 2006 Reproductive Healthcare Ltd, Duck End Farm, Dry Drayton, Cambridge CB23 8DB, UK. Published by Elsevier Inc. All rights reserved.
